Liraglutide

Liraglutide is a peptide-based medication used to treat type 2 diabetes and chronic weight issues. It is a GLP-1 receptor agonist and works by stimulating insulin secretion, suppressing glucagon secretion, reducing appetite, and slowing gastric emptying.

Liraglutide has shown promising results in clinical trials for treating other conditions, including nonalcoholic fatty liver disease, polycystic ovary syndrome, and neurodegenerative diseases. Its potential for use in these conditions is still being researched.